)
Rohto Pharmaceutical (4527) investor relations material
Rohto Pharmaceutical Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Management vision and strategy
Articulates a medium- to long-term vision focused on well-being, longevity, and enhancing corporate value through innovation and regular strategic reviews.
Corporate philosophy centers on contributing to mental and physical health, solving social issues, and sharing benefits with stakeholders.
Emphasizes a rolling approach to management forecasts to adapt to rapid environmental changes.
Business portfolio and market position
Maintains leading market shares in Japan and Asia across eye care, skin care, and internal medicine/food categories.
Reinvests cash from core businesses into high-growth areas like medical and regenerative medicine.
Expands globally, especially in Asia and Europe, through strategic M&A and brand leverage.
Innovation, R&D, and intellectual property
Integrates expertise across eye care, skin care, internal medicine, and regenerative medicine to drive longevity science.
Holds top patent positions in ophthalmic drugs, cosmetics, and related technologies, optimizing IP portfolios for growth.
Advances in cell research, exosome technology, and functional ingredients underpin new product development.
- Double-digit sales and profit growth in Q1 2026, with upwardly revised full-year forecasts.4527
Q1 2027 - Record-high sales and profit growth driven by Asia and Europe, with higher dividends and robust outlook.4527
Q4 2026 - Double-digit sales and profit growth led to upward forecasts and major acquisition integration.4527
Q3 2026 - Strong sales growth, upward guidance, and OBAGI trademark acquisition drive record dividends.4527
Q2 2026 - Sales up 19.9% year-over-year, with profit outlook and dividends raised on overseas growth.4527
Q1 2026 - Sales rose but profits fell on higher costs; full-year outlook and expansion plans remain intact.4527
Q2 2025 - Sales and profit forecasts raised as Asia growth and acquisitions drive outlook.4527
Q1 2025 - Sales surged on overseas growth and acquisitions, but profits faced cost pressures.4527
Q4 2025 - Record sales growth and dividend increase, but profit pressured by higher costs.4527
Q3 2025
Next Rohto Pharmaceutical earnings date
Next Rohto Pharmaceutical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)